No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / urine
-
Cetuximab / administration & dosage
-
Chemoradiotherapy
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
DNA, Neoplasm / analysis
-
DNA, Neoplasm / urine*
-
Fluorouracil / administration & dosage
-
Humans
-
Liquid Biopsy
-
Mitomycin / administration & dosage
-
Muscle, Smooth / pathology
-
Mutation
-
Neoplasm Invasiveness
-
Neoplasm Recurrence, Local / genetics
-
Neoplasm Recurrence, Local / urine*
-
Pilot Projects
-
Receptor, Fibroblast Growth Factor, Type 3 / genetics
-
Sequence Analysis, DNA
-
Telomerase / genetics
-
Treatment Outcome
-
Tumor Suppressor Protein p53 / genetics
-
Urinary Bladder Neoplasms / genetics
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / therapy*
-
Urinary Bladder Neoplasms / urine*
Substances
-
Biomarkers, Tumor
-
DNA, Neoplasm
-
TP53 protein, human
-
Tumor Suppressor Protein p53
-
Mitomycin
-
FGFR3 protein, human
-
Receptor, Fibroblast Growth Factor, Type 3
-
TERT protein, human
-
Telomerase
-
Cetuximab
-
Fluorouracil